From 2011 to 2024, the U.S. government awarded $2.6 million over 151 separate transactions to Innomics, a Massachusetts-based subsidiary of the Beijing Genomics Institute (BGI) Group, a Chinese gene harvesting powerhouse that the Pentagon lists as a "Communist Chinese military company" for its alleged role in supporting Beijing’s ongoing genocide against the Uyghur ethnic minority.

Several of BGI’s affiliates are listed on U.S. government trade blacklists for allegedly fueling the Communist regime’s mass surveillance of citizens. Watchdog groups have also raised concerns that Chinese genome companies like BGI are amassing large quantities of private American health care data via their U.S. affiliates.

Innomics was identified by the Wall Street Journal in May as one of several "blacklisted Chinese companies" that rebranded in recent years to avoid a regulatory crackdown in the United States. The company was formerly called BGI Americas but changed its name last year "to avoid regulatory scrutiny," according to lawmakers on the House China Committee, which is investigating efforts by CCP-tied firms like BGI to obfuscate their operations in America. The taxpayer funding to Innomics highlights how the United States is working to crack down on Chinese companies linked to its military and also funding the very firms reportedly linked to this work.